OM Outset Medical
- 3.510
- +0.410+13.23%
Outset Medical News
Analysts' Top Healthcare Picks: Outset Medical (OM), Cytokinetics (CYTK)
Bank of America Securities Remains a Sell on Outset Medical (OM)
Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating
Outset Medical (OM) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $3 to $9.
Outset Medical Inc (OM) Q1 2024 Earnings: Misses Revenue Estimates and Widens Losses
Outset Medical, Inc. (NASDAQ:OM) Q1 2024 Earnings Call Transcript
Outset Medical | 10-Q: Quarterly report
Outset Medical Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.
Outset Medical Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.
Oppenheimer Sticks to Their Hold Rating for Outset Medical (OM)
Outset Medical Reaffirmed 2024 Revenue Guidance $145M-$153M Vs $148.17M Est.
Outset Medical Reaffirmed 2024 Revenue Guidance $145M-$153M Vs $148.17M Est.
Outset Medical Q1 2024 Adj EPS $(0.57) Misses $(0.55) Estimate, Sales $28.168M Miss $30.341M Estimate
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.55) by 3.64 percent. This is a 20.83 percent increase over losses of $(0.72
Outset Medical CTO Exit Amidst Cost-Cutting Restructure
Outset Medical Backs FY24 Rev $145M-$153M >OM
Outset Medical Backs FY24 Rev $145M-$153M >OM
Earnings Flash (OM) OUTSET MEDICAL Reports Q1 Revenue $28.2M, Vs. Street Est of $30.3M
04:04 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (OM) OUTSET MEDICAL Reports Q1 Revenue $28.2M, vs. Street Est of $30.3M
Outset Medical 1Q Rev $28.2M >OM
Outset Medical 1Q Rev $28.2M >OM
Outset Medical 1Q Loss $39.9M >OM
Outset Medical 1Q Loss $39.9M >OM
Outset Medical 1Q Loss/Shr 78c >OM
Outset Medical 1Q Loss/Shr 78c >OM
Press Release: Outset Medical Reports First Quarter 2024 Financial Results
Outset Medical Reports First Quarter 2024 Financial Results SAN JOSE, Calif.--(BUSINESS WIRE)--May 08, 2024-- Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology comp
Shareholders Can't Ignore US$1.2m Of Sales By Outset Medical Insiders
While Outset Medical, Inc. (NASDAQ:OM) shareholders have enjoyed a good week with stock up 44%, they need remain vigilant. In spite of the relatively cheap prices, insiders made the decision to sell
Why Outset Medical Shares Are Up Today
Outset Medical, Inc. (NASDAQ:OM) shares are trading higher Monday after the company announced that TabloCart with prefiltration received FDA clearance.The Details:Outset said that it has resumed distr
12 Health Care Stocks Moving In Monday's Intraday Session
GainersNRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 39.5% to $2.93 during Monday's regular session. The company's market cap stands at $30.9 million. TC BioPharm (Holdings) (NASDAQ:TCBP) stoc
Analysis
Price Target
No Data
